Skip to main content
European Radiology Experimental
Fig. 2 | European Radiology Experimental

Fig. 2

From: Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model

Fig. 2

Tumor volume in dose response experiment. In the 5th and 6th week, the IMP301 6 mg/kg with FUS group showed the smallest tumor size, followed by the IMP301 4 mg/kg with FUS group. In the 5th week, at doses 4 mg/kg or greater, the IMP301 with FUS group had significantly lower tumor volume compared to control group (p < 0.050; statistical significance indicated as asterisk, *). Arrowheads indicate treatments. DOX Doxil, FUS Focused ultrasound, GEM Gemcitabine, IMP301 Doxorubicin HCl-loaded liposome

Back to article page